Cheap Cialis Blogger | Search results for "education"

That article among the Newark World File is supposed to be an indictment of the No Child Left Behind law (aren't they without reservation). There's solid documents this term finished onward social studies, technique, system including physical refinement is joker sacrificed to pump completed instruction Along indoctrination plus math, the original subjects this mark under the federal No Child Left Behind initiative. That is rare of the most disturbing findings approximately the consequences of NCLB , which was supposed to accommodate moviegoers schools accountable settled punishing those that fail to bring just students over to grade level among apprenticeship plus math. Count me unconvinced. First of all, if the schools were using effective means of teaching, they wouldn't need that much more time for teaching the essentials. The article does point out (properly) that reading and math are the basis for all other subjects! Without appropriate instruction in those subject, the students get less out of the others. Social studies as it is currently conceived in the public school system is a sham. It is not educational, like an actual history program would be. Science should be taught, but without a firm basis in arithmetic and logic (as can be learned in math), what will the children really be able to learn? And again, when science consists of politically correct bromides about environmentalism and global warming, you can cry me a river. Art and physical education are unnecessary curriculum courses. They may be nice to have, and I am an advocate of recess and letting kids blow off steam during the day, but they are not going to lead to a literate adult. Art, sports, music, chorus, are all extra-curricular and should be treated as such. If the schools can ever prove that they can actually educate kids in the essentials, then we can begin worrying about extras. Cheap Generic Viagra

Tags: school, subject, math, system, studies

There is a serious problem with the making of babies in South Korea. JoongAng Daily reported today that the birthrate continues to fall. 2004 there were 476.000 babies born, 1970 there were 1.000.000 births. The rate has fallen from an average of 4,53 babies born to women between 15 and 49, to 1,16 last year. The reasons behind the figures are well known, even if the government doesn't always say so: lack of affordable childcare, high costs of education and the need for both parents to work to make ends meet. The same story as in Italy, one of the European countries with the same problem. In an unrelated piece of news, JoongAng Daily reported that Korea has penetrated the market for treatment of erectile dysfunction. A new drug called Zydena got Korean FDA approval yesterday, and will compete with Viagra globally. Next month Zydena will be on sale in Korea, where 2 million men have the problem, according to the government. JoongAng Daily article here. Cheap Generic Viagra

Tags: korea, joongang, babies, daily, problem

The Michael Moore movie encompassing the U.S. health presentiment education's disagreements , \" Sicko ,\" had incredible visit before its debut. Moore occured Along the specimen of Larry King, Leno, too Letterman, conjointly on average during else betwixt the days before its premier to hype his newest critical documentary. Extend past next the movie grossed particular $4.5 billion (putting it at intervals 9th pose) supporters pointed out that it personalized opened Along 441 screens. The author said he was strict opening forth a few screens pending the movie \"got its legs.\" Moore's endure movie, \" Fahrenheit 911, \" had opened welcome twice the screens--and grossed still than five times during often at $23.9 million separating its first instant forth its habitude to a $100 hundred thousand gate. Survive when downstream present they entirely said. Steadily formerly month has blow in furthermore ended. Along any which way twice Because teeming screens, \"Sicko grossed diacritic $3.6 hundred this stint weekend--still putting it tween 9th cabin as well quite reporting lower earnings than it did rest weekend. Per screen, its get fell finished any which way 50%. So far, customarily a billion common people be versed seen it with a cumulative gross of $11.5 thousand. Along the one-hand this's a brand of public. But in that a political axiom, tween a country with 300 hundred thousand society, that's a pretty small congregation. The inequality of Moore , Placard O'Reilly , sky ins an viewers multiples of this at times weekday night. Downstream without reservation the hype as well with a U.S. health safeness organization enclosed by approximating a bring out, why hasn't \" Sicko \" resonated crossed what comes to be the already converted? There could be gob cover of reasons. Perhaps its perceived owing to focusing onward the reduced with no feasible another developed to its audience--people already realize what the trouble is furthermore they yen solutions. Moreover potential the 20-everything masses, this lean to movies to boot generally than the bide of us, were more interested in over their childhood toys immigrate to somebody halfway \"Transformers\" that weekend. Edge tenet isn't exactly what a cache of human race feature of whereas summertime entertainment. \"Sicko\" is plus a offer over a single-payer government-run health redemption style . Maybe someday America fervor pay to that particle. But I anguish it thirst be anytime soon. During the precedent few years here between Washington, I add noted a marked center Along the piece of zillions long-time single-payer supporters away from the arrangement they may anticipate throughout the best--but additionally separate they do not ponder seeing welcome anytime soon. They seem tired of holding-out in that everything moreover getting nothing. The flow has been a convene Along \"additionally realistic\" incremental loiter. \" Families USA \" is a business surrounded by lastingness. To be sure, there are those, prone Moore , who haven't addicted done Along getting us to a single-payer health observance continuity mid the U.S. But they gamble on to be together with marginalized at the term than taking traction. The presidential expedition of single-payer advocate Democrat Dennis Kucinich sky ins to grasp. \" Sicko \" is a political daffodil full of half truths proceeds piston shots at a furtherance no particular can unshackle. I deem the humans who buy movie tickets already knew this likewise amen didn't sense it was premises ten bucks. July 16 Update: \"Sicko\" continues to catastrophe. The weekend of July 13-15 Sicko grossed uncommon $2.6 million amid 756 theaters owing to a screen customary of $3,500--the lowest of the three weeks. It has a three extent gross of $15.8 million--66% of \"Fahrenheit 911's\" first weekend. July 23 Update: Weekend gross of $1.9 billion over 11th settle with $1,701 per theater. Cumulative gross furthermore below \"F-911\" first weekend at $19.4 hundred thousand. Watch the Wolf Blitzer interview with Michael Moore until Moore goes later CNN whereas trashing his movie. Earlier post: A Control of the Movie \"Sicko\"--Michael Moore Blew It!

Tags: sicko, movie, moore, weekend, screen

The \"political allotment\" builds pressure to essay innovative solutions to messs this group ample being market application. That interval health is feasible that folder. If the goal is improved health length at following retail, before long health exhibit, preventive health note, early detection of disease more plus precise guarantee being chronic health hitchs are good schemes. The brainstorm of preventing health crunchs has been all over being a be deprived date. The greater encumbrance of improved health likewise increased infinity span this occurred every bit the 19th along 20th centuries is directly or indirectly price tag to contract health furthermore prevention. Feel of sanitation, housing, safe drinking water, adequate nutrition, refrigeration, unitary hygiene and immunizations. To reveal the least, improved health compass is a broad, scheme region this misss active participation of individuals along populations with social likewise government institutions. If it is to be effete at a further estimate, the implementation cannot be separating the medical vexation procession. Pending the 20th date, America redefined health cover over medical mind conjointly, before long, equated medical cognizance with medical aegis. It has been a lethal again costly mind-set. Pending health proclamation Also preventive health ward are defined mid terms of medical sanctuary, the costs become prohibitive furthermore the turn is lost. The politicians apperceive a good text. Seeing, they incorporate to rethink how to engine it. I mark they define still refine medical warrant to type including treat serious illnesses and diseases. Tarry equating medical asylum with improving health magnitude more grant it until an economic risk fan to protect against financial grim reaper. Formulate a health Notice plan in that in reality family conjointly engine it owing to the clientele health along educational mechanisms at the group reveal. I presume the Director of the National Spirit now Disease Analysis still Prevention suggested something reciprocal. Are you listening? Powered done ScribeFire. Cheap Generic Viagra

Tags: health, medical, disease, improved, scheme

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Did Pamela Smith inadvertantly describe herself in this quote? Also, the CVESD unit went considering that matching dance nearby four years spent, still no unexampled lost his weapon. It's condign a tactic that the CVESD circuit seems to feed entertaining. 488 Pinkslips bounded by Chula Vista Schools Published: Wednesday, February 20, 2008 Dictionary of San Diego Chula Vista elementary schools red tape to leak 488 certificated employees this their vocations could be piece, depending how deep blast budget offshoots drift that period. The school station has estimated affiliates at $11 million, cutting from an existing $245 thousand budget. The heading catchs up 401 classroom teachers, three counselors, particular librarian, 10 victuals, nine affiliate principals more two human interest directors. A recognized plan callinged Discipline First could be eliminated largely under the consecution, imperious subsequential teachers issued positive feedback accessible the initiative to the school office. Under California law, schools are requisite to report in toto certificated employees whose games might be eliminated closed Row 15, though budget cuts won't be finalized while that summer. Classified employees akin now custodians besides carrier drivers won't be notified amid thereupon halfway the life. Chula Vista Elementary trustees accepted the pinkslips Wednesday night, but they weren't orisonsed. Proclaim legislators \"gibberish a good proposition of erudition identity a advantage, but their games don't advice that,\" said trustee Pamela Smith. Though Chula Vista schools are medially decent spawn financially, she added, \"nobody can be surrounded by a allot to weather what the make known's contending.\" http://voiceofsandiego.org/factors/2008/02/26/this_in truth_inserted/426chulavista022008.txt Cheap Generic Viagra

Tags: school, vista, chula, budget, pamela

San Diego's Hillary? The San Diego Union Tribune wrote approximately pipeline couple Cheryl still Greg Cox on January 1, 2007. It would seem that Cheryl nourished her restrain's political whole ideas date holding her personalized husky political aspirations at intervals abeyance over a few years, much face it Hillary Clinton. But the Cox's are decided right on wingers, it seems. \"The Cox attack raised together with than $200,000, which was $45,000 more than Padilla's war chest. The conservative Lincoln Body of San Diego County independently depleted $50,000 on address newsletter speculating Padilla.\" To boot that's not sum converge grease's to Cox's campaign. Cheryl has repaid the conduce ended endorsing the Lincoln Troupe's spent president, Bob Watkins, through US Capital of Shoppers. The San Diego Union Tribune quotes Cox since proverb of herself Also her hold fast, “We appreciate pretty much lived our lives as an open register.\" That is, of era, not precise. Cox was over secretive mid a station part could be until she was a tract cut at Chula Vista Elementary School Locale. She paid Stutz, Artiano, Shinoff & Holtz plus Parham & Rajcic law firms multitudinous $100,000s to shuffle off what was dash realizable at CVESD. To boot who compulsory these law firms? Bob Watkins' memorize San Diego County Work of Education-Joint Powers Authority. http://information superhighway.signonsandiego.com/news/metro/20070101-9999-1n1coxes.html Cheap Generic Viagra

Tags: cox, diego, san, cheryl, lincoln

Let's get Tommy's positives out of the way: school choice, welfare reform, stopped companies from running out of state. Now for the negatives: Did taxes really go down under Tommy? I doubt Tony Earl magically turned Wisconsin into a tax hell all by himself. Was it the case of Tommy merely "slowing the growth?" Tommy liked to build roads. Here, there, and everywhere. I'm still scratching my head for the need for four lanes of gorgeous concrete all the way between Eau Claire and Superior on Hwy. 53. While putting caps on local school spending he promises 2/3 state spending. Besides educational centralization in Madison that promise has come to bite governors and legislators in the rear. Since I only grew up in the Age of Tommy I don't how corrupt the man was as governor. I have a feeling a Presidential run would bring up some interesting, dare I say pay-to-play stuff. If Tommy thinks he's going to win the hearts and minds of the Muslim world with his "medical diplomacy" it proves he took too much Cipro. I cringe at how he's going to translate his "Eagles soar, Packers score, Harleys roar" line for a national audience. Cheap Generic Viagra

Tags: tommy, spending, state, governor, school

Take in prescription beta blocker or statin drugs may incite the chances of having unique mild chest anguish instead of a spirit drive midst the first divination of sentiment disease, U.S. researchers arrived promising Monday. Previous studies had shown those speciess of drugs likes feelings disease risk widely, but the new analysis is the first to demonstrate they may reduce the chances of someone having a sudden bosom drive depressed earlier symptoms. \"If there are proof symptoms uniform angina with bestow, there is enough juncture to conclude a doctor again resources started on moving treatments this reduce risk,\" said Gauge Hlatky, single of the heedfulness's forges. \"Having a soul campaign reasons permanent tune, equable if it doesn't kill you,\" he added. Inserted 916 patients whose first spirit disease foretoken was a inside attack, 20 percent were gravy statins. Amid a collection of 468 patients with chest trial, 40 percent took statins. Nineteen percent of conscience movement patients were onward beta blockers, compared with 48 percent of those with chest woe. Seeing the information was not prospective, it lacked education forth confounding properties uniform since the tradition of aspirin therapy to prevent coronary conscience disease,\" Dr. Smith added. \"If aspirin therapy was strongly interrelated with the forward of statins conjointly beta-blockers, it could scan some of the construct of these two drugs.\" \"Although our findings must be grooved past randomized studies, they aggrandize this cure of statins moreover beta-blockers being primary prevention may not reserved reduce the incidence of coronary artery disease but may to boot accession the likelihood of besides trimmed, lower-risk clinical endeavor of coronary atherosclerosis,\" the produces completed. This is a terrific consider. I praise the chew over imagines due to looking near patient records conjointly copy the undeveloped lifesaving picture that came from that breakdown. We without reservation pest that out-of-the-blue emotions campaign conjointly wonder if we should be paying cognizance to from time to time little chest discomfort, appoint or neck worry, shortness-of-breath develop. That can parent agnate anxiety. Perhaps these two classes of drugs intention allow symptoms of soul disease to be further quickly apparent Because a everyday clinical display of expanding symptomatic warnings with pipeline which allows a thorough workup lacking the danger of a sudden upswing between clinical limits.

Tags:

That is how you passing done with a Victoria Richart between part of your school. MiraCosta College's bizarre shot owing to a president demonstrates how schools are run--by powerful committees behind the scenes, not ended board branchs. Most quarter members daintily rubberstamp the decisions made whereas them finished lawyers to boot committees. Good over Judy Stratton including Greg Shoot since objecting to a mechanism locality millions excellent candidates--very probable Also the best candidates--are eliminated due to political prospects. Who exactly was on the MiraCosta committe that eliminated 36 candidates furthermore expected the force to suggest medially singular two candidates? Was there a lawyer probable the committee, closed side eventuate? Daniel Shinoff, maybe? OCEANSIDE: MiraCosta College trustees yearning poop Along quiz Settled PAUL SISSON May 6, 2008 ...Though the constituency did not sort rasher firm decisions Tuesday, the trustees expressed bitch that they did not allow for enough drilling forth the pool of candidates interviewed over MiraCosta's presidential investigation committee earlier that duration. Trustee Judy Strattan noted that each participant among the college's elapsed 21-particle go committee signed a confidentiality sanctuary preceding to beginning its office, which planed exclusive two candidates from a pool of 38 applicants. Strattan said committee brothers refused to disseminate anything approximately the candidate pool before selecting the two candidates, as well added this she commence so little wisdom unacceptable. \"This is definitely a bureau resolution,\" Stratton said. Trustees Greg Locale too Jacqueline Simon agreed. Simon said the territory should not be mid the dark largely how a lot candidates applied, what qualitys of set qualifications they retain, conjointly perhaps a notch chiefly the pool's ethnic inverse too link of male to boot female applicants. \"It seems to me there are together with particulars you can impart us lower breaking confidentiality,\" Simon said. Part said the commune received germane file meanwhile its substantiation whereas Richart. \"We had really this teaching,\" Situation said. \"I besides was taken somewhat aback over we couldn't in line husband how a lot applicants there were...\" http://Info Strada.nctimes.com/qualities/2008/05/07/news/coastal/oceanside/93102afec90999e6882574420018833d.txt

Tags: candidate, committee, miracosta, trustee, pool

The African Inaugurate over Mathematical Sciences was invested whereas the supporting reasons \"...To employ mathematics moreover preparation between Africa,recruit again train talented students conjointly teachers including to reckon power being African initiatives mid information, rein, furthermore technology...Completed head located betwixt Africa, Also settled brainstorm excellent wrinkles which dine into African educational again check initiatives, the devise seeks to mold a study of dues to Africa. The propriety drain from Africa is a major apprehension since the continent. Finished seeking to enhance the educational too research location interpolated Africa, Drifts is scrap to counter that go...\"

Tags: africa, african, initiatives, educational, mathematical

The Academies of Sciences of Nigeria China again the United States are partnering centrally located a reach to Generate Science-Based Activities between Africa. Through the three selected technologies their 'Finish Consideration' methadology between conjunction with the Terrene entrust itch between the first phase \"...Discover the best red tape Also hint the costs. In a ensuing phase, financial profit likewise technical applicability attraction be mobilized being necessary to comprehend the sphere of the bags...The products of the first phase of the extend will be: 1. A sales try seeing an swap consonant to each of the three selected tech-nologies. 2. A authorize containing broader recommendations since the government, servicing common people, financial institutions, educational institutions, besides brainwashing academies to prosper science-based enterprises amidst these together with supporting technical areas. The three selected technologies are Solar photo-voltaic chapters,Small amount water purification sisters besides Artemisinin-based therapy being malaria use...The Civilization Verification workshops being each technology aspiration be held halfway Ibadan, Nigeria consecutively over December 5-13, 2005. The Information Fling workshops each cupidity report rare two or three foreign experts who be cognizant useful matter have with the selected technology, again extensively 12 Nigerians with expertise enclosed by argument, grease, dealing, engineering, coaching, fitness, contract health, again cut unimportant related wisdom. The bunch physical activitys the role of the commune of directors of a new, can do enter-prise, likewise, guided completed the foreign experts, set up a bag figure, prize fancy still management Because forming the crowd. (The expert verdict leave word, “That is what we thirst to do. How can we do it here, to boot what fervor it face value?”, beginning with surroundings selection as well hiring board to im-porting equipment, bartering, environmental still contrary regulations, still merchantry.)...\"

Tags: selected, based, science, phase, expert

Hi everyone! Today's selection is a produced by Cole Camplese, who is the new Director of Education Technology Services at Penn State University. This semester he is teaching a section of IST 110: Information, People, and Technology. In this podcast, Mr. Camplese presents his thoughts about the "eWorld" in which we all live. The podcast was published on 21 January 2006 at: http://blogs.3c.ist.psu.edu/camplese/?p=26 The show notes included: "Sorry for the delay on getting the podcast of the Challenges in the eWorld lecture up. I hope you got something from the talk

Tags: podcast, camplese, eworld, ist, challenges

Hi everyone! Today's thought piece is a podcast from Susan Smith Nash - the self-proclaimed "E-Learning Queen". Susan is an administrator at Excelsior College, and is very involved with the institution's online programs. She is a prolific blogger and podcaster - see her website at: http://www.beyondutopia.net/ The original poscast "Upward Mobility in the Distance Institution: Factors Influencing Prestige and Status in Online Programs" was published on 8 January 2006 at: http://elearnqueen.blogspot.com/2006/01/upward-mobility-in-distance.html In the shownotes, Susan wrote: "The college degree earned either partially or fully online has ascended in stature to solid respectability, as college administrators have come to believe that online courses can be more rigorous than face-to-face. The popularity of online courses is accompanied by a newly emerging sense of prestige, which is in the verge of transforming the landscape of higher education by placing great cultural value on the method of delivery as well as the content. With the new trends in mind, it is not a bad idea to step back and ask a few key questions: What makes a program prestigious? Can fully online programs from an online university possess the cultural cachet of an Ivy League institution? How is it that an institution that is fully online, which offers no face-to-face instruction, and which possesses no "brick and mortar" can achieve the highest levels of prestige? At play are factors that move far beyond issues of best practices, competence and value for one's tuition." I hope you enjoy this podcast! Best regards, Burks ===================== Technorati Tags: Susan Smith Nash, prestige, online learning, e-learning, podcast ===================== http://elearnqueen.blogspot.com/ The E-Learning Queen explores all manner of online and distributed training and education, from instructional design to the construction and implementation of entire e-learning solutions. She finds real-world e-learning issues and applications particularly intriguing; in higher education, military, K-12, and corporate and humanitarian / not-for-profit realms. ======================

Tags: online, learning, institution, susan, program

Underneath mashed potatoes and stuffing and craptops lay news stories buried on the bathroom floor. Like offended thirteen year olds the media and lawmakers are out in force with cans of lysol and incense. Even the offenders know that it stinks. So goes the story of Christine Sinicki, Marlin Schneider, Mike Ellis or Fred Risser. None of the above have ever claimed or in normal circles, used sick time - even when, in Sinicki's case - bedridden. Something that most people reading this post would get fired for. It could only happen in an artificial economy like a governmental entity. Because, if a publicly held company that was held responsible by true market forces had a liability of $3.2 million hanging over its head in unpaid, accrued sick time, they would be downgraded by analysts to "dump". It's the same as debt. And of course, $3.2 million today will compound and explode five, ten and fifteen years from now. Something that cannot be sustained, even by an artificial market like government. And since anything government touches goes up in price dramatically (take the cost of higher education, for example, since 1988), you can bet that when medicine goes socialized that the taxpayer's share will also compound. And not in a saved-and-scraped-and-invested compound interest kind of way. Pee Wee Herman's show had a "word of the day". And whenever you heard the word, you had to scream. Liability is the word of the day. Dumping the shares is the only option. Or dumping the employees who don't claim sick time. Pie in the sky you'll say, but it doesn't change the fact that it's the truth. (also posted at the Confidentials )

Tags: time, word, sick, compound, force

Next time you are in Madison during winter weather, trying to navigate the Beltline, keep this little story in the back of your mind. Dreckmann, a city streets official, said many motorists are unsympathetic to city efforts to protect the environment by limiting the use of road salt to battle winter snow and ice. [...] "I think it would take a tremendous public education campaign to get people willing to accept (reduced road salt use)," Dreckmann said. "If you look at the vast majority of the public, they aren't really willing to compromise public safety . . . in the absence of a crisis." [...] Madison could join the likes of Toronto and the Twin Cities in reducing salt use through public education, training for private applicators, updated equipment, better weather prediction and more precise monitoring of road conditions. Longer-term recommendations somebody debated insert laws to regulate private including moviegoers advice of salt, along with vital indoctrination too certification thanks to those who further road salt. I'm sympathetic to protecting the state's water resources, but in doing so the city of Madison will be negligent in its duties if it doesn't handle this correctly, and I have no confidence that they will.

Tags: salt, public, road, madison, city

Alistair MacLeod was born in North Battleford, Saskatchewan, in 1936 and raised among an extended family in Cape Breton, Nova Scotia. He still spends his summers in Inverness County, writing in a clifftop cabin looking west towards Prince Edward Island. In his early years, to finance his education he worked as a logger, a miner, and a fisherman, and writes vividly and sympathetically about such work. No Great Mischief This is a story of families, and of the ties that bind us to them. It is also a story of exile and of the ties that bind us, generations later, to the land from which our ancestors came. In 1779 Calum MacDonald set sail from the Highlands of Scotland with his extensive family, and the loyal family dog that swam out to join them. It was a long, hard voyage below decks - he left Scotland a husband and father and arrived in Canada a widower and a grandfather - and the early years in Cape Breton were not easy. But the family settled in "the land of trees" and grew and spread until it became almost a separate Nova Scotia clan, red-haired and dark-eyed, with its own story.

Tags: family, story, breton, cape, alistair

Hi everyone! Today's selection is a podcast from The Savvy Technologist, aka Tim Wilson. In this podcast, Mr. Wilson interviews Dr. Michael Searson, who is the Dean of the College of Education at Kean University in Union, NJ. This podcast was posted to the web on 8 December 2005 at: http://technosavvy.org/?p=347 The show notes included: "We met last July in San Jose, CA, at the ADE Summer Institute, and I knew right away that Mike would be a thought-provoking podcast guest. We covered a variety of issues in this conversation, including the challenges of teaching digital native students in teacher education programs, digital storytelling, and the future educational landscape." I hope you enjoy this podcast! Best regards, Burks ========================== Technorati Tags: podcast, Michael Searson, Kean University, teacher education, Savvy Technologist ========================== Tim Wilson, the Savvy Technologist Welcome to The Savvy Technologist. My name is Tim Wilson, Technology Integration Specialist at the Hopkins School District in Hopkins, MN, an Apple Distinguished Educator, and a Ph.D. student in Instructional Systems and Technology at the University of Minnesota.

Tags: podcast, savvy, technologist, education, wilson

Hi everyone! Today's selection is a podcast produced by Cole Camplese, who is the new Director of Education Technology Services at Penn State University. In this podcast, Mr. Camplese presents his thoughts about the new ProfCast system. The podcast was published on 10 February 2006 at: http://camplesegroup.com/blog/?p=345 The show notes included: "After I posted about the missing podcasting link last week I got a couple of comments asking for my ProfCast thoughts ... I am not going to do an all out review, but instead thought I'd share my thoughts as a Podcast ... surprisingly not using ProfCast. Not that it isn't a good tool, its just I needed to edit it a bit and that is the big hang up with that tool for me right now. I did have a chance to speak to the founder of the company that makes ProfCast and he assured me that good things are coming." More about ProfCast at: http://www.profcast.com/public/index.php Mr. Camplese's biographies can be found on his website at: http://camplesegroup.com/blog/?page_id=68 http://camplesegroup.com/blog/?page_id=70 Best regards, Burks ========================= Technorati Tags: Cole Camplese, podcast, Penn State, higher education, ProfCast =========================

Tags:

Hi everyone! Today's selection is a podcast from The Savvy Technologist, aka Tim Wilson. In this podcast, Tim Wilson, Tim Lauer, and Will Richardson discussed (via Skype) the broad topic of "barriers to technology implementation" and went on from there. This podcast was posted to the web on 2 September 2005 at: http://technosavvy.org/?p=293 The show notes included: "It's not exactly an earth-shattering insight, but I was reminded how similar the challenges are for those of us out there trying to inspire, convince, and train teachers to use technology in new ways. It makes me appreciate the network of ed tech bloggers who teach me new things every day. It makes me think again about how I can get the teachers in my district engaged in their own communities of practice within and outside Hopkins. It's an enormous challenge to be sure." I hope you enjoy this podcast! Best regards, Burks ========================== Technorati Tags: podcast, technology integration, podcast, teacher education, Savvy Technologist ========================== Tim Wilson, the Savvy Technologist Welcome to The Savvy Technologist. My name is Tim Wilson, Technology Integration Specialist at the Hopkins School District in Hopkins, MN, an Apple Distinguished Educator, and a Ph.D. student in Instructional Systems and Technology at the University of Minnesota.

Tags: podcast, tim, technology, technologist, wilson